← ANALYST RATINGS · TIPRANKS

Option Care Health (OPCH): analyst forecast and price target

$31.20 −0.06% close 16.10.26 · market cap $4.7B · Healthcare · Medical - Care Facilities IWM 0.17%
Price targets and ratings of

Analyst consensus

Hold

2 Buy7 Hold0 Sell

Ratings of 9 analysts in the last 3 months · top analysts only

12-month forecast

$29.36−5.9% downside

Based on 9 price targets given in the last 3 months, the average target is $29.36, the highest $33.00, the lowest $23.00. The average is −5.9% from the last price of $31.20.

$20.00$25.00$30.00$35.00Jan 26AprJulOctJan 27AprJulOctHigh$33.00Average$29.36Low$23.00
Highest target $33.00 Average target $29.36 Lowest target $23.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% Morgan Stanley $28.00 → $32.05+14.5% Hold +2.7% Downgrade 12.10.26on TipRanks 08:00 +0.2%next day 0.0%
Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% J.P. Morgan $33.00 Hold +5.8% Downgrade 10.10.26on TipRanks Oct 12 05:07 +0.2%next day 0.0%
A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% UBS $39.00 → $32.05−17.8% Hold +2.7% Downgrade 09.10.26on TipRanks 08:40 −0.5%next day +0.2% · 5 days +2.4%
Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% J.P. Morgan $33.00 Hold +5.8% Downgrade 07.10.26on TipRanks 08:31 +0.3%next day +0.6% · 5 days +1.3%
Michael Petusky★★★★★★★★★★#4246 · hits 45% · avg +2.3% Barrington — Hold — Downgrade 07.10.26on TipRanks 07:40 +0.3%next day +0.6% · 5 days +1.3%
Brian Tanquilut★★★★★★★★★★#1681 · hits 52% · avg +6.6% Jefferies $28.00 → $32.05+14.5% Hold +2.7% Downgrade 06.10.26on TipRanks 16:40 +0.3%next day +0.6% · 5 days +1.3%
David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% Truist Financial — Buy — Reiterated 06.10.26on TipRanks 07:45 +32.1%next day +0.3% · 5 days +0.5%
Matt Larew★★★★★★★★★★#816 · hits 63% · avg +19.3% William Blair — Buy — Reiterated 06.10.26on TipRanks 02:55 +32.1%next day +0.3% · 5 days +0.5%
Charles Rhyee★★★★★★★★★★#1937 · hits 54% · avg +5.6% TD Cowen $23.00 Hold −26.3% Reiterated 02.08.26on TipRanks 23:15 +1.5%next day −1.8% · 5 days +1.3%
Michael Petusky★★★★★★★★★★#4246 · hits 45% · avg +2.3% Barrington $32.00 → $33.00+3.1% Buy +5.8% Reiterated 30.07.26on TipRanks 09:30 −7.8%next day +1.8% · 5 days +1.6%
David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% Truist Financial $30.00 Buy −3.8% Reiterated 30.07.26on TipRanks 07:57 −7.8%next day +1.8% · 5 days +1.6%
Pito Chickering★★★★★★★★★★#1500 · hits 61% · avg +9.8% Deutsche Bank $26.00 → $24.00−7.7% Hold −23.1% Downgrade 30.07.26on TipRanks 05:21 −7.8%next day +1.8% · 5 days +1.6%
Joanna Gajuk★★★★★★★★★★#5858 · hits 54% · avg +1.2% Bank of America Securities $25.00 Hold −19.9% Reiterated 29.07.26on TipRanks Jul 30 06:50 +8.0%next day −7.8% · 5 days −6.5%
Matt Larew★★★★★★★★★★#816 · hits 63% · avg +19.3% William Blair — Buy — Reiterated 29.07.26on TipRanks 11:36 +8.0%next day −7.8% · 5 days −6.5%
Raj Kumar CFA★★★★★★★★★★#3375 · hits 77% · avg +21.7% Stephens $30.00 → $24.00−20.0% Hold −23.1% Downgrade 17.07.26on TipRanks 06:21 −0.6%next day +0.2% · 5 days +0.2%
A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% UBS $39.00 Buy +25.0% Reiterated 16.06.26on TipRanks 07:42 +2.4%next day +1.7% · 5 days +3.8%
Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% Goldman Sachs $22.00 Hold −29.5% Initiated 08.06.26on TipRanks Jun 9 05:25 −2.3%next day +5.4% · 5 days +3.6%
Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% Morgan Stanley $38.00 → $28.00−26.3% Buy −10.3% Reiterated 06.05.26on TipRanks 08:20 −5.4%next day +1.8% · 5 days −4.4%
Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% J.P. Morgan $40.00 → $33.00−17.5% Buy +5.8% Assigned 04.05.26on TipRanks 08:00 +5.9%next day 0.0% · 5 days −9.2%
Constantine Davides★★★★★★★★★★#12158 · hits 36% · avg −12.7% Citizens JMP $38.00 → $32.00−15.8% Buy +2.6% Reiterated 30.04.26on TipRanks 15:50 −25.3%next day −1.8% · 5 days +0.3%
Unknown Analyst Jefferies $43.00 Buy +37.8% Reiterated 25.03.26on TipRanks 14:35 −0.3%next day −0.8% · 5 days −6.8%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Option Care Health

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Matt Larew★★★★★★★★★★William Blair · #816
Hits 63%90 of 142 Average return +19.3%
1 year David S Macdonald★★★★★★★★★★Truist Financial · #400
Hits 63%312 of 499 Average return +13.2%
2 years Matt Larew★★★★★★★★★★William Blair · #816
Hits 63%90 of 142 Average return +19.3%

Most profitable

3 months David S Macdonald★★★★★★★★★★Truist Financial · #400
Hits 63%312 of 499 Average return +13.2%
1 year Matt Larew★★★★★★★★★★William Blair · #816
Hits 63%90 of 142 Average return +19.3%
2 years Matt Larew★★★★★★★★★★William Blair · #816
Hits 63%90 of 142 Average return +19.3%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $26.50 at a price of $22.49 (+17.8%); now: $28.74 at $31.20 (−7.9%).

$22.50$25.00$27.50$30.00Sep 15Oct 1Oct 15Top analysts$29.36Average target$28.74Price$31.20

PriceAverage targetTop analysts’ target

Recommendation trend · top analysts

051015181Oct 25182Nov172Dec62Jan 26102Feb1113Mar1103Apr482May472Jun482Jul143Aug32Sep27Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy444100
Buy878432
Hold222327
Sell000000

Earnings and sales forecast

Next report: 04.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.49 (from $0.48 to $0.50). Last quarter: $0.45.

Sales

Next quarter’s sales estimate — $1.5B (from $1.5B to $1.5B). Last quarter: $1.4B.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Option Care Health

Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.

Data from the stock’s TipRanks forecast page, read 32 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗